bioRxivCancer BiologyPreprint
High LET Particle Therapy Targets Tumor Microtube Networks in Glioblastoma
Ivana ĐokićiD, Federica Ciamarone, Dirk C. HoffmanniD, Jovana Bojcevski, Damir KruniciD, Thomas TessonnieriD, Jürgen DebusiD, Andrea MairaniiD, Varun VenkataramaniiD, Amir AbdollahiiD
Abstract
PurposeTumor cell networks formed by tumor microtubes (TMs) are thought to drive therapy resistance in glioblastoma (GB). X-ray irradiation enhances TM formation, thereby increasing radioresistance. We hypothesize that high linear energy transfer (LET) particle radiotherapy is less affected by TM-mediated resistance due to its reduced reliance on indirect DNA damage. This study explores the impact of LET-induced DNA damage on TMs formation and GB survival Material and MethodsFormation of TMs was investigated in the primary patient derived glioblastoma stem-like cell lines (S24 and T269) irradiated with different LET, ranging from 3 - 107 keV/{micro}m, across dose series (1, 2, 4, 6 Gy) of clinical proton, helium, and carbon ion beams. TM networks and DNA damage patterns, specifically {gamma}H2AX foci, were visualized using fluorescence microscopy. Cell survival was evaluated through clonogenic survival assays. ResultsThe formation of TMs, radiation-induced nuclear DNA damage repair foci, and GB cell survival were correlated with a gradual increase in LET. Consistent with conventional photon/X-rays, low-LET proton irradiation promoted TMs formation in a dose-dependent manner. In contrast, an anti-correlation between LET and TMs induction was found, i.e., a decreased network connectivity with gradual increase of LET and formation of complex DNA damage. Consequently, LET increase correlated with reduced cell survival, with the most pronounced cell killing observed after high-LET carbon irradiation. Moreover, the inverse correlation between LET and TMs density was further confirmed for a broad range of LET modulated within the carbon ion irradiation. ConclusionThis is the first report on the relevance of LET as a novel mean to overcome TMs network-mediated radioresistance in GB, with ramifications for the clinical translation of high-LET particle radiotherapy to further improve outcome in this still devastating disease.
- organism: human
- assay: imaging
- research focus: cancer & tumor microenvironment
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Biomimetic model for the identification of distinctive microenvironmental factors in glioblastoma radiosensitivity
Ryan Yao, Isabella Rivera, … Sara Pedrón·Clinical and Translational Radiation OncologyPeer-reviewed·May 30, 2026
- Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma
D. M. Tiek, J. D. Rone, … R. B. Riggins·bioRxiv·Dec 14, 2017
- Ex vivo stem-like cell families model evolution of glioblastoma therapeutic resistance
Marta Prelli, Francesca De Bacco, … Carla Boccaccio·bioRxiv·Apr 6, 2026
- Microphysiological system modeling pericyte-induced temozolomide resistance in glioblastoma
Surjendu Maity, Christopher Jewell, … Vadim Jucaud·Acta BiomaterialiaPeer-reviewed·May 16, 2025
- Expanding Microgel Parameters to Model the Tumor Microenvironment and Examine Temozolomide Resistance in Glioblastoma
Brittany A. Payan, Joel Kattoor, … Brendan A.C. Harley·bioRxiv·Jul 9, 2026
- Patient-derived Glioblastoma Stem cells transfer mitochondria through Tunneling Nanotubes in Tumor Organoids
G. PINTO, I. SAENZ DE SANTA MARIA, … C. ZURZOLO·bioRxiv·Nov 21, 2020